Farmacología

2016

1. A Tetra-Primer Amplification Refractory System Technique for the Cost-Effective and Novel Genotyping of Eight Single-Nucleotide Polymorphisms of the Catechol-O-Methyltransferase Gene

   Genetic Testing and Molecular Biomarkers, Vol. 20, Núm. 8, pp. 465-470

2. A cannabinoid link between mitochondria and memory

   Nature, Vol. 539, Núm. 7630, pp. 555-559

3. Activation of the orphan receptor GPR55 by lysophosphatidylinositol promotes metastasis in triple-negative breast cancer

   Oncotarget, Vol. 7, Núm. 30, pp. 47565-47575

4. Activity of muscarinic, galanin and cannabinoid receptors in the prodromal and advanced stages in the triple transgenic mice model of Alzheimer's disease

   Neuroscience, Vol. 329, pp. 284-293

5. Advances in nanomedicine for the treatment of Alzheimer's and Parkinson's diseases

   Nanomedicine, Vol. 11, Núm. 10, pp. 1267-1285

6. Allosteric signaling through an mGlu2 and 5-HT2A heteromeric receptor complex and its potential contribution to schizophrenia

   Science Signaling, Vol. 9, Núm. 410

7. Alpha2C-adrenoceptor Del322-325 polymorphism and risk of psychiatric disorders: significant association with opiate abuse and dependence

   World Journal of Biological Psychiatry, Vol. 17, Núm. 4, pp. 308-315

8. Altered CSNK1E, FABP4 and NEFH protein levels in the dorsolateral prefrontal cortex in schizophrenia

   Schizophrenia Research, Vol. 177, Núm. 1-3, pp. 88-97

9. Biased agonism of three different cannabinoid receptor agonists in mouse brain cortex

   Frontiers in Pharmacology, Vol. 7, Núm. NOV

10. Buspirone requires the intact nigrostriatal pathway to reduce the activity of the subthalamic nucleus via 5-HT1A receptors

    Experimental Neurology, Vol. 277, pp. 35-45

11. CNTNAP2 Mutations in Autism

    Neuronal and Synaptic Dysfunction in Autism Spectrum Disorder and Intellectual Disability (Elsevier Inc.), pp. 177-188

12. CYP2C9 variants as a risk modifier of NSAID-related gastrointestinal bleeding: A case-control study

    Pharmacogenetics and Genomics, Vol. 26, Núm. 2, pp. 66-73

13. Can the past predict the future?

    Science Translational Medicine

14. Cannabinoids and Motor Control of the Basal Ganglia: Therapeutic Potential in Movement Disorders

    CANNABINOIDS IN HEALTH AND DISEASE (INTECH EUROPE), pp. 59-92

15. Chronic L-DOPA administration increases the firing rate but does not reverse enhanced slow frequency oscillatory activity and synchronization in substantia nigra pars reticulata neurons from 6-hydroxydopamine-lesioned rats

    Neurobiology of Disease, Vol. 89, pp. 88-100

16. Cystine/glutamate antiporter blockage induces myelin degeneration

    GLIA, Vol. 64, Núm. 8, pp. 1381-1395

17. Data for the morphometric characterization of NT2-derived postmitotic neurons

    Data in Brief

18. Depressive-like behavior observed with a minimal loss of locus coeruleus (LC) neurons following administration of 6-hydroxydopamine is associated with electrophysiological changes and reversed with precursors of norepinephrine

    Neuropharmacology, Vol. 101, pp. 76-86

19. Dipeptidyl peptidase-IV inhibitors induced bullous pemphigoid: A case report and analysis of cases reported in the European pharmacovigilance database

    Journal of Clinical Pharmacy and Therapeutics, Vol. 41, Núm. 3, pp. 368-370

20. Effect of subchronic corticosterone administration on α2-adrenoceptor functionality in rat brain: an in vivo and in vitro study

    Psychopharmacology, Vol. 233, Núm. 23-24, pp. 3861-3867